The authors suggest that the discrepancies between FHL2-overexpressing rat ovary phenotype and that of PCOS patients may be explained by partial involvement of FHL2 in the ovarian features of PCOS. The gene discussed is FHL2; the disease is polycystic ovary syndrome.